Radnor Capital Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $227K | Sell |
2,641
-200
| -7% | -$17.5K | 0.03% | 297 |
|
|
2026
Q1 | $257K | Hold |
2,841
| – | – | 0.04% | 283 |
|
|
2025
Q4 | $255K | Hold |
2,841
| – | – | 0.04% | 288 |
|
|
2025
Q3 | $280K | Hold |
2,841
| – | – | 0.04% | 285 |
|
|
2025
Q2 | $259K | Hold |
2,841
| – | – | 0.04% | 288 |
|
|
2025
Q1 | $322K | Hold |
2,841
| – | – | 0.05% | 270 |
|
|
2024
Q4 | $300K | Hold |
2,841
| – | – | 0.05% | 272 |
|
|
2024
Q3 | $307K | Hold |
2,841
| – | – | 0.05% | 284 |
|
|
2024
Q2 | $308K | Buy |
2,841
+500
| +21% | +$58.9K | 0.09% | 138 |
|
|
2024
Q1 | $309K | Sell |
2,341
-66
| -3% | -$8.24K | 0.05% | 270 |
|
|
2023
Q4 | $293K | Buy |
2,407
+66
| +3% | +$7.36K | 0.05% | 271 |
|
|
2023
Q3 | $263K | Hold |
2,341
| – | – | 0.05% | 273 |
|
|
2023
Q2 | $341K | Hold |
2,341
| – | – | 0.15% | 97 |
|
|
2023
Q1 | $302K | Hold |
2,341
| – | – | 0.08% | 175 |
|
|
2022
Q4 | $301K | Hold |
2,341
| – | – | 0.07% | 204 |
|
|
2022
Q3 | $245K | Sell |
2,341
-33
| -1% | -$3.62K | 0.07% | 209 |
|
|
2022
Q2 | $249K | Hold |
2,374
| – | – | 0.07% | 210 |
|
|
2022
Q1 | $304K | Sell |
2,374
-71
| -3% | -$8.56K | 0.08% | 198 |
|
|
2021
Q4 | $302K | Hold |
2,445
| – | – | 0.07% | 203 |
|
|
2021
Q3 | $347K | Buy |
+2,445
| New | +$360K | 0.21% | 70 |
|
|
2021
Q2 | – | Sell |
-2,517
| Closed | -$391K | – | 218 |
|
|
2021
Q1 | $391K | Hold |
2,517
| – | – | 0.13% | 159 |
|
|
2020
Q4 | $377K | Hold |
2,517
| – | – | 0.11% | 158 |
|
|
2020
Q3 | $333K | Buy |
2,517
+82
| +3% | +$10.7K | 0.11% | 152 |
|
|
2020
Q2 | $282K | Buy |
2,435
+72
| +3% | +$8.3K | 0.1% | 145 |
|
|
2020
Q1 | $232K | Hold |
2,363
| – | – | 0.1% | 146 |
|
|
2019
Q4 | $343K | Sell |
2,363
-40
| -2% | -$5.52K | 0.11% | 141 |
|
|
2019
Q3 | $320K | Hold |
2,403
| – | – | 0.1% | 136 |
|
|
2019
Q2 | $275K | Hold |
2,403
| – | – | 0.09% | 154 |
|
|
2019
Q1 | $298K | Hold |
2,403
| – | – | 0.1% | 146 |
|
|
2018
Q4 | $242K | Buy |
2,403
+206
| +9% | +$23.2K | 0.09% | 159 |
|
|
2018
Q3 | $280K | Hold |
2,197
| – | – | 0.09% | 160 |
|
|
2018
Q2 | $238K | Hold |
2,197
| – | – | 0.09% | 162 |
|
|
2018
Q1 | $233K | Sell |
2,197
-206
| -9% | -$23.9K | 0.08% | 162 |
|
|
2017
Q4 | $282K | Hold |
2,403
| – | – | 0.09% | 155 |
|
|
2017
Q3 | $300K | Hold |
2,403
| – | – | 0.1% | 150 |
|
|
2017
Q2 | $300K | Hold |
2,403
| – | – | 0.1% | 150 |
|
|
2017
Q1 | $285K | Hold |
2,403
| – | – | 0.1% | 152 |
|
|
2016
Q4 | $241K | Buy |
+2,403
| New | +$258K | 0.08% | 166 |
|
Other funds holding ZBH
Radnor Capital Management's ZBH Position: Q2 2026 in Review
Radnor Capital Management reduced its Zimmer Biomet (ZBH) stake by 7% in Q2 2026, selling an estimated $17.5K and leaving 2,641 shares worth $227K. The position accounts for 0.03% of the portfolio, ranked #297.
Radnor Capital Management first reported a position in ZBH in Q4 2016 and has held it in 38 quarters since. The position peaked at $391K in Q1 2021. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Radnor Capital Management held 2,641 shares of Zimmer Biomet worth $227K as of Q2 2026.
- Radnor Capital Management sold 200 Zimmer Biomet shares in Q2 2026, an estimated $17.5K.
- Zimmer Biomet made up 0.03% of Radnor Capital Management's portfolio in Q2 2026, its #297 holding.
- Radnor Capital Management first reported a position in Zimmer Biomet in Q4 2016 and has held it in 38 quarters since.
- Radnor Capital Management's Zimmer Biomet position peaked at $391K in Q1 2021.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Radnor Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.